During the past decade, Harlem AIDS Treatment Group / Harlem Hosp Ctr conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials, followed by "Pfizer" with 3 trials sponsored, "City University of New York" with 1 trials sponsored, "Columbia University" with 1 trials sponsored and "Glaxo Wellcome" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" #1 collaborator was "Glaxo Wellcome" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Fujisawa Pharmaceutical Co" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" are "HIV Infections" (26 trials), "Pneumonia, Pneumocystis Carinii" (5 trials), "Tuberculosis" (5 trials), "Meningitis, Cryptococcal" (3 trials) and "Candidiasis" (1 trials). Many other conditions were trialed in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" in a lesser frequency.

Most popular intervention types in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" are "Drug" (21 trials), "Behavioral" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fluconazole" (4 trials), "Amphotericin B" (3 trials), "Isoniazid" (3 trials), "Pyridoxine hydrochloride" (3 trials) and "Atovaquone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" are 26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Harlem AIDS Treatment Group / Harlem Hosp Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Harlem AIDS Treatment Group / Harlem Hosp Ctr, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Harlem AIDS Treatment Group / Harlem Hosp Ctr, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".